Takeda Beats Antitrust Claims In Heartburn Drug Patent Fight
A New Jersey federal judge on Monday tossed generic-drug maker Zydus Pharmaceuticals Inc.'s antitrust counterclaims accusing Takeda Pharmaceutical Co. Ltd. of filing sham patent litigation to delay competition for heartburn medication...To view the full article, register now.
Already a subscriber? Click here to view full article